Day: September 4, 2023
BBS-Bioactive Bone Substitutes Plc, Company announcement, 4 September 2023 at 09.45 a.m. EET
BBS-Bioactive Bone Substitutes has resolved on a share issue without consideration to the company itself
BBS-Bioactive Bone Substitutes Plc’s Board of Directors has decided on 3 September 2023 to issue 500,000 shares without consideration to the company itself, for potential loan conversions as well as for other possible purposes, in accordance with authorisation from the Extraordinary Shareholders’ Meeting on 30 March, 2023.
After the directed share issue, the Company holds 601,451 treasury shares, representing approximately 4.1 percent of the total shares and votes of the company.
For more information:Ilkka Kangasniemi, CEO,tel. +358 40 708 0307, e-mail: ilkka.kangasniemi@bbs-artebone.fi
Certified Advisor:Nordic Certified Adviser...